Howard Marks BRIDGEBIO PHARMA INC Transaction History

Oaktree Capital Management LP

18,056,000

Previous 14,135,000 27.74%

Previous $0 NaN%

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	N/A	3,921,000 Added 27.74%	18,056,000 $0
Q1 2025 May 14, 2025	BUY	N/A	10,337,000 Added 272.17%	14,135,000 $0
Q4 2024 Feb 12, 2025	BUY	N/A	1,416,000 Added 59.45%	3,798,000 $0
Q3 2024 Nov 14, 2024	SELL	N/A	-1,436,000 Reduced 37.61%	2,382,000 $0
Q2 2024 Aug 13, 2024	BUY	N/A	289,000 Added 8.19%	3,818,000 $0
Q1 2024 May 14, 2024	SELL	N/A	-1,498,000 Reduced 29.8%	3,529,000 $0
Q4 2023 Feb 13, 2024	SELL	N/A	-1,458,000 Reduced 22.48%	5,027,000 $0
Q3 2023 Nov 13, 2023	SELL	N/A	-802,000 Reduced 11.01%	6,485,000 $0
Q2 2023 Aug 11, 2023	BUY	N/A	3,303,000 Added 82.91%	7,287,000 $0
Q1 2023 Aug 25, 2023	SELL	N/A	-3,303,000 Reduced 45.33%	3,984,000 $0
Q1 2023 May 15, 2023	BUY	N/A	3,984,000 New	3,984,000 $0

Get notified when there are updates to the investment portfolio of Oaktree Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Oaktree Capital Management LP and Howard Marks with notifications on news.